Conservative fertility-sparing surgical treatment of invasive epithelial ovarian cancer: When is it acceptable?

Israel Medical Association Journal

Volumn 15, Issue 2, 2013, Pages 116-120

  Menczer, Joseph ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adjuvant chemotherapy; Fertility sparing surgery; Ovarian cancer

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); FERTILITY; FOLLOW UP; HUMAN; OVARY CARCINOMA; OVARY CYST; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY;

ADULT; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INFERTILITY, FEMALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY;

EID: 84874203693     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Munnell EW. Is conservative therapy ever justified in stage I (IA) cancer of the ovary? Am J Obstet Gynecol 1969; 103 (5): 641-53.
2. Heinz APM, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynecol Obstet 2006; 95 (Suppl 1): S161-92.
3. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357 (9251): 176-82.
4. Heffner LJ. Advanced maternal age-how old is too old? N Engl J Med 2004; 351: 1927-9.
5. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 1994; 55 (Pt 2): S47-51.
6. Colombo N, Parma G, Lapresa MT, Maggi F, Piantanida P, Maggioni A. Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer 2005; 15 (Suppl 3): 206-11.
7. Morice P, Wicart-Poque F, Rey A, et al. Results of conservative treatment in epithelial ovarian carcinoma. Cancer 2001; 92: 2412-18.
8. Morice P, Leblanc E, Rey A, et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique). Hum Reprod 2005; 20: 1379-85.
9. Zanetta G, Chiari S, Rota S, et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997; 104: 1030-5.
10. Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002; 87: 1-7.
11. Park JY, Kim DY, Suh DS, et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008; 110: 345-53.
12. Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer 2009; 19: 1199-204.
13. Cheng X, Cheng B, Wan X, Lu W, Xie X. Outcomes of conservative surgery in early epithelial ovarian carcinoma. Eur J Gynaecol Oncol 2012; 33: 93-5.
14. Morice P, Camatte S, Wicart-Poque F, et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update 2003; 9: 185-92.
15. Jobo T, Yonaha H, Iwaya H, Kanai T, Kuramoto H. Conservative surgery for malignant ovarian tumor in women of childbearing age. Int J Clin Oncol 2000; 5: 41-7.
16. Borgfeldt C, Iosif C, Måsbäck A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007; 134: 110-14.
17. Smaldone GM, Richard SD, Edwards RP. Pregnancy outcomes after conservative surgical management of ovarian neoplasms treated at a single institution. Int J Gynecol Cancer 2010; 20: 926-31.
18. Ghaemmaghami F, Karimi Zarchi M, et al. Fertility sparing in young women with ovarian tumors. Clin Exp Obstet Gynecol 2010; 37: 290-4.
19. Raspagliesi F, Fontanelli R, Paladini D, di Re EM. Conservative surgery in high risk epithelial ovarian carcinoma. J Am Coll Surg 1997; 185: 457-60.
20. Dembo AJ, Davy M, Stanwig AE, Berle EJ, Bush RS, Kjorstad K. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990; 75: 263-73.
21. Ahmed FY, Wiltshaw E, A'Hern RP, et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 1996; 14: 2968-75.
22. Sjovall K, Nilsson B, Einhorn N. Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer 1994; 4: 333-6.
23. Kodama S, Tanaka K, Tokunaga A, Sudo N, Takahashi T, Matsui K. Multivariate analysis of prognostic factors in patients with ovarian cancer stage I and II. Int J Gynaecol Obstet 1997; 56: 147-53.
24. Sainz de la Cuesta R, Goff BA, Fuller AF Jr, Nikrui N, Eichhorn JH, Rice LW. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms. Obstet Gynecol 1994; 84: 1-7.
25. Higashi M, Kajiyama H, Shibata K, et al. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types. Gynecol Oncol 2011; 123: 474-8.
26. Mizuno M, Kikkawa F, Shibata K, et al. Long term prognosis of stage I ovarian carcinoma: prognostic importance of intraoperative rupture. Oncology 2003; 65: 29-36.
27. Bakkum-Gamez JN, Richardson DL, Seamon LG, et al. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol 2009; 113: 11-17.
28. Paulsen T, Kærn J, Tropé C. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Gynecol Oncol 2011; 122 (1): 83-8. Epub 2011 Mar 23.
29. Fanfani F, Fagotti A, Ercoli A, et al. A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. Hum Reprod 2004; 19: 2367-71.
30. Maltaris T, Beckmann MW, Dittrich R. Fertility preservation for young female cancer patients [Review]. In Vivo 2009; 23: 123-30.
31. Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 1999; 72: 288-91.